Detection of CDH1 gene promoter hypermethylation in gastric cancer and chronic gastritis

IF 1.7 Q3 MEDICAL LABORATORY TECHNOLOGY
Mitra Bayat , Amir Shirgir , Arash Kazemi Veisari , Rouhallah Najjar Sadeghi
{"title":"Detection of CDH1 gene promoter hypermethylation in gastric cancer and chronic gastritis","authors":"Mitra Bayat ,&nbsp;Amir Shirgir ,&nbsp;Arash Kazemi Veisari ,&nbsp;Rouhallah Najjar Sadeghi","doi":"10.1016/j.plabm.2024.e00406","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>The current study aimed to assess the frequency of <em>CDH1</em> promoter gene hypermethylation in gastric cancer and chronic gastritis and its correlation with clinicopathological aspects.</p></div><div><h3>Methods</h3><p>Methylation-specific PCR was used to detect CDH1 promoter gene hypermethylation in 53 chronic gastritis patients and 40 gastric cancer patients along with normal adjacent tissues.</p></div><div><h3>Results</h3><p>The chronic gastritis group comprised 29 males and 24 females with a mean age of 51.8 ± 12.96 years, and 49.1 % of them were positive for H. pylori infection. The frequency of <em>CDH1</em> hypermethylation in gastritis lesions was 18.8 %. <em>CDH1</em> hypermethylation showed a significant correlation with H. pylori infection (p = 0.039), but no significant association was observed with other clinical features. The gastric cancer group consisted of individuals with a mean age of 65.4 ± 10.6, among them, 77.5 % were male and 22.5 % were female, 62.5 % had PT3 tumors, 40 % had PN1 lymph node involvement, and the majority (47.5 %) of samples were obtained from body segment. <em>CDH1</em> hypermethylation was significantly associated with depth of invasion (p = 0.017) and nodal invasion (p = 0.041) in this group. In both groups, normal adjacent specimens lacked CDH1 hypermethylation, and there was no statistically significant correlation between CDH1 hypermethylation and age at which the tumor was diagnosed, gender, activity level, or tumor location.</p></div><div><h3>Conclusion</h3><p>This study demonstrates that E-cadherin methylation is associated with some characteristics of chronic gastritis and gastric cancer. These findings support previous research indicating that CDH1 hypermethylation may play a significant role in the development of gastric cancer.</p></div>","PeriodicalId":20421,"journal":{"name":"Practical Laboratory Medicine","volume":"40 ","pages":"Article e00406"},"PeriodicalIF":1.7000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352551724000520/pdfft?md5=8c6ac4ad32e9fc2fa93d69467d9c5744&pid=1-s2.0-S2352551724000520-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352551724000520","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

The current study aimed to assess the frequency of CDH1 promoter gene hypermethylation in gastric cancer and chronic gastritis and its correlation with clinicopathological aspects.

Methods

Methylation-specific PCR was used to detect CDH1 promoter gene hypermethylation in 53 chronic gastritis patients and 40 gastric cancer patients along with normal adjacent tissues.

Results

The chronic gastritis group comprised 29 males and 24 females with a mean age of 51.8 ± 12.96 years, and 49.1 % of them were positive for H. pylori infection. The frequency of CDH1 hypermethylation in gastritis lesions was 18.8 %. CDH1 hypermethylation showed a significant correlation with H. pylori infection (p = 0.039), but no significant association was observed with other clinical features. The gastric cancer group consisted of individuals with a mean age of 65.4 ± 10.6, among them, 77.5 % were male and 22.5 % were female, 62.5 % had PT3 tumors, 40 % had PN1 lymph node involvement, and the majority (47.5 %) of samples were obtained from body segment. CDH1 hypermethylation was significantly associated with depth of invasion (p = 0.017) and nodal invasion (p = 0.041) in this group. In both groups, normal adjacent specimens lacked CDH1 hypermethylation, and there was no statistically significant correlation between CDH1 hypermethylation and age at which the tumor was diagnosed, gender, activity level, or tumor location.

Conclusion

This study demonstrates that E-cadherin methylation is associated with some characteristics of chronic gastritis and gastric cancer. These findings support previous research indicating that CDH1 hypermethylation may play a significant role in the development of gastric cancer.

胃癌和慢性胃炎中 CDH1 基因启动子高甲基化的检测
目的 本研究旨在评估CDH1启动子基因高甲基化在胃癌和慢性胃炎中的发生频率及其与临床病理的相关性。方法 采用甲基化特异性PCR技术检测53例慢性胃炎患者和40例胃癌患者及邻近正常组织的CDH1启动子基因高甲基化情况。胃炎病变中 CDH1 高甲基化的频率为 18.8%。CDH1 高甲基化与幽门螺杆菌感染有显著相关性(p = 0.039),但与其他临床特征无显著相关性。胃癌组的平均年龄为(65.4 ± 10.6)岁,其中77.5%为男性,22.5%为女性,62.5%为PT3肿瘤,40%为PN1淋巴结受累,大部分样本(47.5%)来自体节。在该组中,CDH1高甲基化与浸润深度(p = 0.017)和结节浸润(p = 0.041)显著相关。在两组中,正常邻近标本均缺乏 CDH1 高甲基化,CDH1 高甲基化与肿瘤确诊年龄、性别、活动水平或肿瘤位置之间没有统计学意义上的显著相关性。这些发现支持了之前的研究,表明 CDH1 高甲基化可能在胃癌的发展中起着重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Practical Laboratory Medicine
Practical Laboratory Medicine Health Professions-Radiological and Ultrasound Technology
CiteScore
3.50
自引率
0.00%
发文量
40
审稿时长
7 weeks
期刊介绍: Practical Laboratory Medicine is a high-quality, peer-reviewed, international open-access journal publishing original research, new methods and critical evaluations, case reports and short papers in the fields of clinical chemistry and laboratory medicine. The objective of the journal is to provide practical information of immediate relevance to workers in clinical laboratories. The primary scope of the journal covers clinical chemistry, hematology, molecular biology and genetics relevant to laboratory medicine, microbiology, immunology, therapeutic drug monitoring and toxicology, laboratory management and informatics. We welcome papers which describe critical evaluations of biomarkers and their role in the diagnosis and treatment of clinically significant disease, validation of commercial and in-house IVD methods, method comparisons, interference reports, the development of new reagents and reference materials, reference range studies and regulatory compliance reports. Manuscripts describing the development of new methods applicable to laboratory medicine (including point-of-care testing) are particularly encouraged, even if preliminary or small scale.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信